Business Context and Reporting Period
This Form 8-K reports on the 2012 annual meeting of stockholders for Ventrus Biosciences, Inc. (note: the request metadata lists "Assembly Biosciences, Inc.", but the filing text identifies the registrant as Ventrus Biosciences, Inc.). The meeting was held on May 8, 2012.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
Director Elections
Stockholders elected five members to the board of directors for a term expiring in 2013. All nominees received significant support with minimal votes against:
- Anthony Altig: 7,443,627 for; 25,623 against.
- Mark Auerbach: 7,431,685 for; 37,565 against.
- Russell H. Ellison: 7,439,959 for; 29,291 against.
- Joseph Felder: 7,436,935 for; 32,315 against.
- Myron Z. Holubiak: 7,431,935 for; 37,315 against.
Executive Compensation (Say-on-Pay)
The nonbinding advisory resolution approving executive compensation was approved:
- For: 6,829,220 shares
- Against: 645,118 shares
- Abstaining: 45,948 shares
Frequency of Say-on-Pay Votes
Stockholders voted on the frequency of future advisory votes on executive compensation. The results were:
- Every 3 Years: 3,620,710 shares (Highest support)
- Every 1 Year: 3,042,311 shares
- Every 2 Years: 816,322 shares
Management decided to hold these advisory votes every three years based on the results.
Independent Auditor Ratification
Stockholders ratified the appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2012:
- For: 11,285,637 shares
- Against: 46,379 shares
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirm the correct registrant name is Ventrus Biosciences, Inc., not Assembly Biosciences, Inc.
- Verify the board composition changes effective from the May 8, 2012 meeting.
- Note the company's decision to conduct executive compensation advisory votes every three years.
- Confirm EisnerAmper LLP's role as the independent auditor for the 2012 fiscal year.